SpyBiotech

About:

SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.

Twitter/X: SpyBiotech

Top Investors: Oxford Science Enterprises, Bill & Melinda Gates Foundation, Google Ventures, Oxford Investment Consultants LLP, The Future Fund

Description:

SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines which give better results in lesser time.

Total Funding Amount:

$41.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2017-01-01

Contact Email:

contact(AT)spybiotech.com

Founders:

Jing Jin, Mark Howarth, Simon Draper, Sumi Biswas

Number of Employees:

11-50

Last Funding Date:

2023-03-20

IPO Status:

Private

Industries: